Literature DB >> 6764767

New medium for differentiation of Cryptococcus neoformans serotype pairs.

I F Salkin, N J Hurd.   

Abstract

A new medium effectively differentiates B and C serotypes of Cryptococcus neoformans from A and D serotypes on the basis of resistance to low concentrations of cycloheximide and assimilation of glycine as the sole carbon source.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6764767      PMCID: PMC272046          DOI: 10.1128/jcm.15.1.169-171.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  The Production, Assay, and Antibiotic Activity of Actidione, an Antiobiotic from Streptomyces griseus.

Authors:  A J Whiffen
Journal:  J Bacteriol       Date:  1948-09       Impact factor: 3.490

2.  The antigenic composition of Cryptococcus neoformans. I. A serologic classification by means of the capsular and agglutination reactions.

Authors:  E E EVANS
Journal:  J Immunol       Date:  1950-05       Impact factor: 5.422

3.  Serologic grouping of Cryptococcus neoformans.

Authors:  D E Wilson; J E Bennett; J W Bailey
Journal:  Proc Soc Exp Biol Med       Date:  1968-03

4.  A new species of Filobasidiella, the sexual state of Cryptococcus neoformans B and C serotypes.

Authors:  K J Kwon-Chung
Journal:  Mycologia       Date:  1976 Jul-Aug       Impact factor: 2.696

5.  Epidemiologic differences among serotypes of Cryptococcus neoformans.

Authors:  J E Bennett; K J Kwon-Chung; D H Howard
Journal:  Am J Epidemiol       Date:  1977-06       Impact factor: 4.897

6.  Biochemical differences between serotypes of Cryptococcus neoformans.

Authors:  J E Bennett; K J Kwon-Chung; T S Theodore
Journal:  Sabouraudia       Date:  1978-09
  6 in total
  19 in total

1.  Cryptococcosis in AIDS.

Authors:  P Imwidthaya; N Poungvarin
Journal:  Postgrad Med J       Date:  2000-02       Impact factor: 2.401

2.  Cryptococcosis associated with AIDS in the Muñiz Hospital of Buenos Aires.

Authors:  A J Bava; R Negroni; A Arechavala; A M Robles; M Bianchi
Journal:  Mycopathologia       Date:  1997       Impact factor: 2.574

3.  Isolation of highly encapsulated Cryptococcus neoformans serotype B from a patient in New York City.

Authors:  E J Bottone; P A Kirschner; I F Salkin
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

4.  Comparison of the sensitivity of three methods for the rapid identification of Cryptococcus neoformans.

Authors:  J Cohen
Journal:  J Clin Pathol       Date:  1984-03       Impact factor: 3.411

5.  Taxonomic studies on Filobasidiella species and their anamorphs.

Authors:  K J Kwon-Chung; J E Bennett; J C Rhodes
Journal:  Antonie Van Leeuwenhoek       Date:  1982       Impact factor: 2.271

6.  Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C).

Authors:  K J Kwon-Chung; I Polacheck; J E Bennett
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948

7.  Growth and pigment production on D-tryptophan medium by Cryptococcus gattii, Cryptococcus neoformans, and Candida albicans.

Authors:  Stuart Chaskes; Susana Frases; Michael Cammer; Gary Gerfen; Arturo Casadevall
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

8.  Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates.

Authors:  S P Franzot; I F Salkin; A Casadevall
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Presence of C. albidus, C. laurentii and C. uniguttulatus in crop and droppings of pigeon lofts (Columba livia).

Authors:  I Rosario; G Soro; S Déniz; O Ferrer; F Acosta; D Padilla; B Acosta
Journal:  Mycopathologia       Date:  2009-12-10       Impact factor: 2.574

10.  Projecting global occurrence of Cryptococcus gattii.

Authors:  Deborah J Springer; Vishnu Chaturvedi
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.